Gemcitabine as a single-agent treatment for ovarian cancer.

Gynecologic oncology

Volumn 90, Issue 2 Pt 2, 2003, Pages

  Fowler Jr , Wesley C ^a   Van Le, Linda ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE;

CANCER STAGING; CLINICAL TRIAL; FEMALE; HUMAN; OVARY TUMOR; PATHOLOGY; REVIEW; TUMOR RECURRENCE;

ANTIMETABOLITES, ANTINEOPLASTIC; CLINICAL TRIALS; DEOXYCYTIDINE; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS;

MLCS; MLOWN;

EID: 17344391596     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0090-8258(03)00340-8     Document Type: Review

References (9)